TMPRSS2 and prostate carcinoma: Rearrangements involving androgen-regulated TMPRSS2 and ETS family members (ERG, RTV1, ETV4) were detected in nearly half of the prostate cancers but none of the benign prostate tissues that were tested [5,39].